Tmax in three treatment, three period, three sequence design [Nonparametrics]

posted by libaiyi – China, 2019-04-09 09:15 (1448 d 15:18 ago) – Posting: # 20134
Views: 2,453

Dear all,

I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?

Thanks in advance!

Best,

Libaiyi

Complete thread:

UA Flag
Activity
 Admin contact
22,554 posts in 4,724 threads, 1,606 registered users;
12 visitors (1 registered, 11 guests [including 5 identified bots]).
Forum time: 00:33 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5